Screener
Twist Bioscience Corporation TWST Reportable Segment — Other Income (Expense)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (in thousands) | Three months ended March 31, 2026 | Three months ended March 31, 2025 | Six months ended March 31, 2026 | Six months ended March 31, 2025 |
|---|---|---|---|---|
| Stock-based compensation expense | 18,936 | 20,328 | 32,209 | 32,319 |
| Total costs and expenses | $156,578 | $134,353 | $293,176 | $257,711 |
| Loss from operations | $(45,863) | $(41,560) | $(78,763) | $(76,205) |
| Interest income | $1,710 | $2,801 | $3,885 | $6,041 |
| Other income (expense), net | 175 | (394) | 646 | (487) |
| Income (loss) before income taxes | $(43,978) | $(39,153) | $(74,232) | $(70,651) |
| Income tax expense | (43) | (175) | (296) | (271) |
| Net loss | $(44,021) | $(39,328) | $(74,528) | $(70,922) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's reportable segment — other income (expense)?
- Twist Bioscience Corporation (TWST) reported reportable segment — other income (expense) of $175K in Q1 2026.
- How has Twist Bioscience Corporation's reportable segment — other income (expense) changed year-over-year?
- Twist Bioscience Corporation's reportable segment — other income (expense) increased by 144.4% year-over-year, from -$394K to $175K.
- What does reportable segment — other income (expense) mean?
- This metric represents the net total of non-operating income and expenses generated by the reportable segment that are not directly related to core business operations. It includes items such as foreign exchange gains or losses, miscellaneous financial income, and other incidental charges. Monitoring this helps investors understand the impact of peripheral financial activities on the segment's bottom line.
Ask your AI about Twist Bioscience Corporation's reportable segment — other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude